7711 - 7720 of 9140 Results
Title
Year
-
OPENTitle: Systematic Functional Analysis of PINK1 and PRKN Coding VariantsJournal Name: CellsPublisher: MDPI AGVol: 11Issue #: 15Start Page: 2426End Page: 2426Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/cells11152426Best OA location URL: https://www.mdpi.com/2073-4409/11/15/2426/pdf?version=1659696395Citation Count: 26
-
OPENTitle: PARKIN, PINK1, and DJ1 analysis in early-onset Parkinson’s disease in IrelandJournal Name: Irish Journal of Medical Science (1971 -)Publisher: Springer Science and Business Media LLCVol: 191Issue #: 2Start Page: 901End Page: 907Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s11845-021-02563-wBest OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9376961Citation Count: 13
- Pathological structural conversion of α-synuclein at the mitochondria induces neuronal toxicity2022OPENTitle: Pathological structural conversion of α-synuclein at the mitochondria induces neuronal toxicityJournal Name: Nature NeurosciencePublisher: Springer Science and Business Media LLCVol: 25Issue #: 9Start Page: 1134End Page: 1148Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41593-022-01140-3Best OA location URL: https://www.nature.com/articles/s41593-022-01140-3.pdfCitation Count: 253
-
OPENTitle: The safety/tolerability of opicapone when used early in Parkinson's disease patients with levodopa-induced motor fluctuations: A post-hoc analysis of BIPARK-I and IIJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 13Issue #:Start Page: 994114End Page: 994114Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2022.994114Best OA location URL: https://doi.org/10.3389/fneur.2022.994114Citation Count: 8
-
OPENTitle: Dopaminergic Positron Emission Tomography Imaging in the Alpha‐Synuclein Preformed Fibril Model Reveals Similarities to Early Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 8Start Page: 1739End Page: 1748Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.29051Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29051Citation Count: 14
-
OPENTitle: Generation of realistic synthetic data using Multimodal Neural Ordinary Differential EquationsJournal Name: npj Digital MedicinePublisher: Springer Science and Business Media LLCVol: 5Issue #: 1Start Page: 122End Page: 122Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41746-022-00666-xBest OA location URL: https://www.nature.com/articles/s41746-022-00666-x.pdfCitation Count: 26
-
OPENTitle: Methionine oxidation activates pyruvate kinase M2 to promote pancreatic cancer metastasisJournal Name: Molecular CellPublisher: Elsevier BVVol: 82Issue #: 16Start Page: 3045End Page: 3060.e11Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.molcel.2022.06.005Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9391305Citation Count: 74
- Adjuvant medical therapy in cervical dystonia after deep brain stimulation: A retrospective analysis2022OPENTitle: Adjuvant medical therapy in cervical dystonia after deep brain stimulation: A retrospective analysisJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 13Issue #:Start Page: 927573End Page: 927573Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2022.927573Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2022.927573/pdfCitation Count: 4
-
OPENTitle: The Parkinson’s disease protein alpha-synuclein is a modulator of processing bodies and mRNA stabilityJournal Name: CellPublisher: Elsevier BVVol: 185Issue #: 12Start Page: 2035End Page: 2056.e33Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.cell.2022.05.008Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9394447Citation Count: 168
-
OPENTitle: Preclinical and randomized clinical evaluation of the p38α kinase inhibitor neflamapimod for basal forebrain cholinergic degenerationJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page: 5308End Page: 5308Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-022-32944-3Best OA location URL: https://www.nature.com/articles/s41467-022-32944-3.pdfCitation Count: 60